Illumina To Webcast Upcoming Investor Conference
Get Alerts ILMN Hot Sheet
Join SI Premium – FREE
SAN DIEGO--(BUSINESS WIRE)-- Illumina, Inc. (NASDAQ: ILMN) today announced that its executives will be speaking at the following investor conference:
-
Goldman Sachs 42nd Annual Global Healthcare Conference on June 10, 2021
Fireside Chat at 7:30 am Pacific Time / 10:30 am Eastern Time
The live webcast can be accessed under the Investor Info section of the "company" tab at www.illumina.com. A replay will be posted on Illumina’s website after the event and will be available for at least 30 days following.
About Illumina
Illumina is improving human health by unlocking the power of the genome. Our focus on innovation has established us as the global leader in DNA sequencing and array-based technologies, serving customers in the research, clinical and applied markets. Our products are used for applications in the life sciences, oncology, reproductive health, agriculture and other emerging segments. To learn more, visit www.illumina.com and connect with us on Twitter, Facebook, LinkedIn, Instagram, and YouTube.
View source version on businesswire.com: https://www.businesswire.com/news/home/20210527005739/en/
Investors:
Brian Blanchett
+1.858.291.6421
[email protected]
Media:
Dr. Karen Birmingham
+1.646.355.2111
[email protected]
Source: Illumina, Inc.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- TRUQAP® (capivasertib) combination approved in the US as first and only targeted treatment for PTEN-deficient metastatic hormone-sensitive prostate cancer
- Zillow Group Securities Fraud Class Action Arising from Alleged Anticompetitive Agreement and Related Regulatory Risks - Investors May Contact Lewis Kahn, Esq., at Kahn Swick & Foti, LLC
- Generational Group Advises The Nutmeg Companies, Inc. in its Sale to a Private Investment Group
Create E-mail Alert Related Categories
Business Wire, Press ReleasesRelated Entities
Goldman Sachs, TwitterSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share